NeuExcell Therapeutics

About:

NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.

Website: https://neuexcell.com/

Top Investors: Innoangel Fund, Foothill Ventures, Oriza Seed Capital (Oriza Yuandian), Suzhou International Development Venture Capital, Guangzhou Financial Holding Fund Management

Description:

NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. We have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion. Our vision is to improve the quality of life of millions of patients worldwide who are suffering from neurodegenerative conditions by using the power of gene therapy to restore damaged neural tissue.

Total Funding Amount:

$25M

Headquarters Location:

State College, Pennsylvania, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)neuexcell.com

Founders:

Gong Chen, Jie Xu

Number of Employees:

11-50

Last Funding Date:

2023-05-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai